RECOMBINATE 1000 IU

Land: Israël

Taal: Engels

Bron: Ministry of Health

Werkstoffen:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Beschikbaar vanaf:

TEVA MEDICAL MARKETING LTD.

ATC-code:

B02BD02

farmaceutische vorm:

POWDER FOR SOLUTION FOR INJECTION

Toedieningsweg:

I.V

Geproduceerd door:

BAXTER S.A., BELGIUM

Therapeutische categorie:

COAGULATION FACTOR VIII

therapeutische indicaties:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Autorisatie datum:

2010-07-01